SYRE
NASDAQ:SYRE
Spyre Group
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.spyre.comipo date
Apr 07, 2016
Spyre Therapeutics, Inc., a biotechnology company, focuses on advancing a pipeline of antibody therapeutics for the treatment of inflammatory bowel disease by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. The company's pipeline includes extended half-life antibodies targeting a4ß7, TL1A, and IL-23. Th...Show More